Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34,723,329
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
21,665,346
-
Shares change
-
-1,342,643
-
Total reported value, excl. options
-
$132,375,397
-
Value change
-
-$11,575,882
-
Put/Call ratio
-
60%
-
Number of buys
-
34
-
Number of sells
-
-23
-
Price
-
$6.11
Significant Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q4 2024
92 filings reported holding IGMS - IGM Biosciences, Inc. - Common Stock, par value $0.01 per share as of Q4 2024.
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,665,346 shares
of 34,723,329 outstanding shares and own 62% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,094,304 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,568,999 shares), Siren, L.L.C. (3,330,422 shares), Redmile Group, LLC (2,952,131 shares), Sanofi (1,438,975 shares), BlackRock, Inc. (1,054,028 shares), GOLDMAN SACHS GROUP INC (978,485 shares), VANGUARD GROUP INC (896,350 shares), FMR LLC (473,426 shares), and STATE STREET CORP (459,451 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.